Penn Mutual Asset Management’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $602K | Hold |
62,802
| – | – | 1.06% | 23 |
|
|
2025
Q1 | $394K | Hold |
62,802
| – | – | 0.76% | 39 |
|
|
2024
Q4 | $510K | Hold |
62,802
| – | – | 0.92% | 30 |
|
|
2024
Q3 | $1.14M | Hold |
62,802
| – | – | 2.25% | 9 |
|
|
2024
Q2 | $647K | Hold |
62,802
| – | – | 1.38% | 11 |
|
|
2024
Q1 | $667K | Hold |
62,802
| – | – | 1.42% | 13 |
|
|
2023
Q4 | $573K | Hold |
62,802
| – | – | 0.44% | 50 |
|
|
2023
Q3 | $651K | Hold |
62,802
| – | – | 0.61% | 45 |
|
|
2023
Q2 | $899K | Hold |
62,802
| – | – | 0.81% | 42 |
|
|
2023
Q1 | $448K | Hold |
62,802
| – | – | 0.43% | 46 |
|
|
2022
Q4 | $705K | Sell |
62,802
-24,138
| -28% | -$271K | 0.79% | 37 |
|
|
2022
Q3 | $963K | Hold |
86,940
| – | – | 1.26% | 29 |
|
|
2022
Q2 | $734K | Hold |
86,940
| – | – | 0.99% | 30 |
|
|
2022
Q1 | $1.18M | Buy |
+86,940
| New | +$1.18M | 1.37% | 18 |
|
|
2021
Q4 | – | Sell |
-86,940
| Closed | -$2.79M | – | 68 |
|
|
2021
Q3 | $2.79M | Hold |
86,940
| – | – | 4.41% | 7 |
|
|
2021
Q2 | $2.94M | Hold |
86,940
| – | – | 3.68% | 8 |
|
|
2021
Q1 | $3.27M | Hold |
86,940
| – | – | 3.69% | 10 |
|
|
2020
Q4 | $2.89M | Hold |
86,940
| – | – | 2.55% | 12 |
|
|
2020
Q3 | $3.19M | Hold |
86,940
| – | – | 4.5% | 10 |
|
|
2020
Q2 | $2.86M | Buy |
+86,940
| New | +$2.86M | 2.92% | 13 |
|